This study systematically investigated the association of CSF complement proteins (C1q, C2, C5, C6, C8B, and CFB) with cognitive decline, AD pathology and brain structures, as well as the mediation effects of regional brain structures on cognition. This evidence concerns the gene VTN and Alzheimer disease.